 inhibit proteoglycan synthesi human articular cartilag cartilag normal control patient osteoarthr patient rheumatoid arthriti cultur massiv product ng/ml cartilag sourc dose-depend manner case peak valu level induc similar rheumatoid arthriti synovi fluid concentr complet inhibit proteoglycan PG synthesi product exogen PG synthesi inhibit PG synthesi antibodi recombin human result inhibit PG synthesi